Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Apyx Medical Q2 Gaap EPS $(0.19) Beats $(0.20) Estimate, Sales $12.15M Beat $11.75M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:21pm
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 72.73 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $12.15 million which beat the analyst consensus estimate of $11.75 million by 3.40 percent. This is a 10.47 percent decrease over sales of $13.57 million the same period last year.

Posted In: APYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist